Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology
Capitalizing on Synthetic Lethality of MYC to Treat Cancer in the Digital Age: Trends in Pharmacological Sciences
c-Myc Metabolic Addiction in Cancers Counteracted by Resveratrol and NQO2 | IntechOpen
Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts | EMBO Molecular Medicine
Direct and indirect inhibition of MYC. (A) Targeting the MYC/MAX... | Download Scientific Diagram
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy
Targeting oncogenic Myc as a strategy for cancer treatment | Signal Transduction and Targeted Therapy
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML
Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer | SpringerLink
Long path to MYC inhibition approaches clinical trials
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML
Alternative approaches to target Myc for cancer treatment | Signal Transduction and Targeted Therapy
Small-molecule inhibitors of c-Myc transcriptional factor suppress proliferation and induce apoptosis of promyelocytic leukemia cell via cell cycle arrest - Molecular BioSystems (RSC Publishing)
IJMS | Free Full-Text | The Molecular 'Myc-anisms' behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics | HTML
Therapeutic targeting of “undruggable” MYC - eBioMedicine
Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc | Molecular Cancer | Full Text
De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition | Molecular Systems Biology
Targeting MYC: From understanding its biology to drug discovery - ScienceDirect
Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus - ScienceDirect
MYC inhibitors in multiple myeloma
Frontiers | Strategies to Inhibit Myc and Their Clinical Applicability | Cell and Developmental Biology
Reproducibility in Cancer Biology: Small molecules remain on target for c- Myc | eLife
